11C-methionine in the diagnostics and management of glioblastoma patients with rapid early progressi...
11C-methionine in the diagnostics and management of glioblastoma patients with rapid early progression: nonrandomized, open label, prospective clinical trial (GlioMET)
About this item
Full title
Author / Creator
Lakomý, Radek , Lojová, Martina , Souckova, Lenka , Hynkova, Ludmila , Polachova, Katerina , Vasina, Jiri , Demlová, Regina , Poprach, Alexandr , Sana, Jiri , Prochazka, Tomas , Smrcka, Martin , Fadrus, Pavel , Jancalek, Radim , Selingerova, Iveta , Belanova, Renata , Slampa, Pavel , Pospisil, Petr and Kazda, Tomas
Publisher
London: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
London: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Background Glioblastoma (GBM) is the most common and aggressive primary brain cancer. The treatment of GBM consists of a combination of surgery and subsequent oncological therapy, i.e., radiotherapy, chemotherapy, or their combination. If postoperative oncological therapy involves irradiation, magnetic resonance imaging (MRI) is used for radiothera...
Alternative Titles
Full title
11C-methionine in the diagnostics and management of glioblastoma patients with rapid early progression: nonrandomized, open label, prospective clinical trial (GlioMET)
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_bebe9980a0a64643b438dbf725e4abd3
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_bebe9980a0a64643b438dbf725e4abd3
Other Identifiers
ISSN
1471-2407
E-ISSN
1471-2407
DOI
10.1186/s12885-024-12469-2
